153 related articles for article (PubMed ID: 11326261)
1. Knocking the SOCS off a tumor suppressor.
Kishimoto T; Kikutani H
Nat Genet; 2001 May; 28(1):4-5. PubMed ID: 11326261
[No Abstract] [Full Text] [Related]
2. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity.
Yoshikawa H; Matsubara K; Qian GS; Jackson P; Groopman JD; Manning JE; Harris CC; Herman JG
Nat Genet; 2001 May; 28(1):29-35. PubMed ID: 11326271
[TBL] [Abstract][Full Text] [Related]
3. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.
Chen T; Wang LH; Farrar WL
Cancer Res; 2000 Apr; 60(8):2132-5. PubMed ID: 10786674
[TBL] [Abstract][Full Text] [Related]
5. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
Podewski EK; Hilfiker-Kleiner D; Hilfiker A; Morawietz H; Lichtenberg A; Wollert KC; Drexler H
Circulation; 2003 Feb; 107(6):798-802. PubMed ID: 12591746
[TBL] [Abstract][Full Text] [Related]
6. Negative regulation of cytokine signaling by the SOCS proteins.
Nicola NA; Nicholson SE; Metcalf D; Zhang JG; Baca M; Farley A; Willson TA; Starr R; Alexander W; Hilton DJ
Cold Spring Harb Symp Quant Biol; 1999; 64():397-404. PubMed ID: 11232314
[No Abstract] [Full Text] [Related]
7. A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells.
Flowers LO; Subramaniam PS; Johnson HM
Oncogene; 2005 Mar; 24(12):2114-20. PubMed ID: 15688010
[TBL] [Abstract][Full Text] [Related]
8. Silencing of negative regulator of JAK/STAT in colorectal cancer.
Endo T; Toyota M; Imai K
J Gastroenterol; 2004; 39(2):200-1. PubMed ID: 15198092
[No Abstract] [Full Text] [Related]
9. Inhibition of signal transducer and activator transcription factor 3 in rats with acute hepatic failure.
Kamohara Y; Sugiyama N; Mizuguchi T; Inderbitzin D; Lilja H; Middleton Y; Neuman T; Demetriou AA; Rozga J
Biochem Biophys Res Commun; 2000 Jun; 273(1):129-35. PubMed ID: 10873574
[TBL] [Abstract][Full Text] [Related]
10. A family of cytokine-inducible inhibitors of signalling.
Starr R; Willson TA; Viney EM; Murray LJ; Rayner JR; Jenkins BJ; Gonda TJ; Alexander WS; Metcalf D; Nicola NA; Hilton DJ
Nature; 1997 Jun; 387(6636):917-21. PubMed ID: 9202125
[TBL] [Abstract][Full Text] [Related]
11. [Induction of SOCS family proteins in inflammatory diseases and suppression of inflammatory arthritis model by the adenovirus gene transfer].
Yoshimura A; Shouda T; Yoshida T; Hanada T
Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2355-61. PubMed ID: 12518461
[No Abstract] [Full Text] [Related]
12. [Advances in basic research on Janus kinase/signal transducer and activators of transcription pathway and sepsis].
Wang SB; Yao YM
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Nov; 15(11):690-3. PubMed ID: 14604492
[No Abstract] [Full Text] [Related]
13. Modulation of Janus kinase 2 by cisplatin in cancer cells.
Song H; Sondak VK; Barber DL; Reid TJ; Lin J
Int J Oncol; 2004 Apr; 24(4):1017-26. PubMed ID: 15010843
[TBL] [Abstract][Full Text] [Related]
14. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.
Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F
Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646
[TBL] [Abstract][Full Text] [Related]
15. Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathway.
Park ES; Kim H; Suh JM; Park SJ; You SH; Chung HK; Lee KW; Kwon OY; Cho BY; Kim YK; Ro HK; Chung J; Shong M
Mol Endocrinol; 2000 May; 14(5):662-70. PubMed ID: 10809230
[TBL] [Abstract][Full Text] [Related]
16. Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling.
Pezet A; Favre H; Kelly PA; Edery M
J Biol Chem; 1999 Aug; 274(35):24497-502. PubMed ID: 10455112
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
18. Cytokine signaling in the brain: putting a SOCS in it?
Wang J; Campbell IL
J Neurosci Res; 2002 Feb; 67(4):423-7. PubMed ID: 11835308
[TBL] [Abstract][Full Text] [Related]
19. Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line.
To KF; Chan MW; Leung WK; Ng EK; Yu J; Bai AH; Lo AW; Chu SH; Tong JH; Lo KW; Sung JJ; Chan FK
Br J Cancer; 2004 Oct; 91(7):1335-41. PubMed ID: 15354212
[TBL] [Abstract][Full Text] [Related]
20. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells.
Park ES; Kim H; Suh JM; Park SJ; Kwon OY; Kim YK; Ro HK; Cho BY; Chung J; Shong M
Mol Endocrinol; 2000 Mar; 14(3):440-8. PubMed ID: 10707961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
